Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta
Clinical trial NCT01252355 · TERMINATED
Trial details
- NCT number
- NCT01252355
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2013-04-01
- Enrollment
- 534
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.